All News

The nonprofit, which is focused on advancing the cannabis industry, joins a network of industry experts from over a hundred different organizations.

The final installment of this webinar series discussed recommendations for new policies integrating cannabis into harm reduction efforts.

At the Cannabis Science Conference Spring 2024, toxicologist Cristelle Santos provided a deep dive into the need for better cannabis product safety standards.

This hour-long webinar covered consumer safety, interstate commerce, and the need for global standards, highlighting collaboration and evidence-based approaches for future regulatory frameworks.

Here we present a roundup of the interviews, insights, and presentation coverage from both before and during this year’s conference in Kansas City, Missouri from May 7-9, 2024.

In this interview at the Cannabis Science Conference, James Wylde, President and CEO of Greenlight Analytical, discusses new cannabis cultivation tools.

Focusing on the potential effects for medical cannabis patients, Americans for Safe Access held a high-level presentation and discussion on the rescheduling of cannabis.

The US Attorney General has initiated the process to reclassify cannabis from a Schedule I to a less-restrictive Schedule III substance.

At the Cannabis Science Conference, Antonio Timoteo Jr., PhD, presented research on cannabis cultivation practices and optimizing terpene content.

In the General Session of the Cannabis Science Conference, Scheril Murray Powell, Esq. and John Calloway Jr. discussed the many ways equity ties into science in the cannabis industry.

Multiple sources have reported that the US Drug Enforcement Administration will move to reclassify marijuana from Schedule I to Schedule III, effectively recognizing medical uses of cannabis and its reduced potential for abuse compared with other drugs.

In the second installment in this webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon discuss implementation of cannabis as a harm reduction agent from a clinical perspective.

Our sister publication, LCGC International, sat down with Zacariah Hildenbrand, PhD, Chief Science Officer of Infinity Water Solutions and Partner of Medusa Analytical, for more insight into various trends in cannabis testing.

Kentucky Governor signs HB 829, and introduces lottery for dispensary applications.

Trilogene Seeds recently announced the release of their new triploid THCa cannabis seeds.

In recognizing the 4/20 holiday, here is a selection of regulatory updates and commentary in the cannabis industry this year so far.

As we celebrate the 4/20 holiday, here is a selection of medical cannabis coverage we have explored in the cannabis industry this year so far.

The cannabis business license application system has raised concerns with several stakeholders.

Recreational cannabis legalization in New Hampshire encounters another setback.

The plant-based material hempcrete is slowly being used in more construction projects in the US, highlighting its versatility.

A collection of our most recent webinar coverage discussing medical research and testing methods.

This month’s Healer webinar provided a deep dive into six studies on cannabis for various conditions.

In the first installment of a three-part webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon share their insights on cannabis as a harm reduction option.

A New York (NY) judge struck down most of the state’s cannabis regulations last week before scaling back on their decision.

Several efforts have been made to limit the prevalence of intoxicating hemp products.

The contrast between cannabis for medical and recreational use in Canada since their respective legalizations.

One step forward, two steps back: updates on cannabis legal movements in three different states.

Several recent survey results, including from the Pew Research Center, show an increase in support and interest in cannabis in the US.